35.00
1.00 (2.94%)
| Previous Close | 34.00 |
| Open | 33.95 |
| Volume | 320,346 |
| Avg. Volume (3M) | 178,003 |
| Market Cap | 578,397,568 |
| Price / Sales | 0.720 |
| Price / Book | 43.86 |
| 52 Weeks Range | |
| Earnings Date | 7 Nov 2025 |
| Profit Margin | -126.96% |
| Operating Margin (TTM) | 4.21% |
| Diluted EPS (TTM) | -72.90 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 31,271.65% |
| Current Ratio (MRQ) | 1.02 |
| Operating Cash Flow (TTM) | 27.84 M |
| Levered Free Cash Flow (TTM) | 140.38 M |
| Return on Assets (TTM) | 0.83% |
| Return on Equity (TTM) | -198.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Mixed |
| Health Information Services (Global) | Bearish | Mixed | |
| Stock | Claritev Corporation | Bearish | - |
AIStockmoo Score
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | -0.50 |
|
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.81% |
| % Held by Institutions | 82.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| H&F Corporate Investors Viii, Ltd. | 30 Sep 2025 | 5,387,858 |
| Cpv Partners, Llc | 30 Sep 2025 | 495,258 |
| 52 Weeks Range | ||
| Median | 80.00 (128.57%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 10 Nov 2025 | 80.00 (128.57%) | Buy | 57.84 |
| 22 Oct 2025 | 74.00 (111.43%) | Buy | 66.08 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 24 Nov 2025 | Announcement | Claritev Corporation Announces Participation at Upcoming Conferences |
| 12 Nov 2025 | Announcement | Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders |
| 12 Nov 2025 | Announcement | Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders |
| 07 Nov 2025 | Announcement | Claritev Corporation Reports Third Quarter 2025 Results |
| 27 Oct 2025 | Announcement | Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region |
| 16 Oct 2025 | Announcement | Claritev Corporation Announces Third Quarter 2025 Earnings Conference Call |
| 08 Oct 2025 | Announcement | Claritev and iO Health Forge Strategic Relationship to Bring AI-Powered Revenue Cycle Management Optimization to the MENA Region |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |